BioMérieux Financial Statements From 2010 to 2026

Pink Sheets . USA . 
Stock . bioMrieux SA
BMXMF Stock  USD 111.10  10.22  8.42%   
BioMérieux's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BioMérieux's valuation are provided below:
bioMrieux SA does not presently have any fundamental signals for analysis.
Check BioMérieux financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioMérieux's main balance sheet or income statement drivers, such as , as well as many indicators such as . BioMérieux financial statements analysis is a perfect complement when working with BioMérieux Valuation or Volatility modules.
  
This module can also supplement various BioMérieux Technical models . Check out the analysis of BioMérieux Correlation against competitors.

Currently Active Assets on Macroaxis

MSFTMicrosoft
DDDupont De Nemours
WDWalker Dunlop
GOOGAlphabet Inc Class C
CRMSalesforce

Other Information on Investing in BioMérieux Pink Sheet

BioMérieux financial ratios help investors to determine whether BioMérieux Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioMérieux with respect to the benefits of owning BioMérieux security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY